Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Taraneh Rehage"'
Autor:
Guili Zhang, Deepa Jethwaney, Partha Das, Kelli DeMartin, Taraneh Rehage, Sylwia Karwowska, Karen Yu, John W. Longshore
Publikováno v:
Journal of Thrombosis and Thrombolysis
Laboratory testing for thrombophilia is complicated but essential for diagnosis. In 2017, the cobas® Factor II and Factor V Test (cobas F2F5 test) was launched for use with the cobas z 480 analyzer. This qualitative polymerase chain reaction test en
Autor:
Jing Li, Alan Blair, Harkanwal Halait, Stephanie Gan, Taraneh Rehage, Corey Hoeppner, Victoria H. Brophy, Kyungji Min
Publikováno v:
Archives of pathologylaboratory medicine. 143(2)
Context.— KRAS Mutation Test v2 is used for the qualitative detection and identification of 28 mutations in exons 2, 3, and 4 of the human KRAS gene. Objective.— To verify the performance of KRAS Mutation Test v2 and to evaluate its accuracy by c
Autor:
Robert Current, Mari Christensen, Warren Maltzman, Taraneh Rehage, Sean Shih-Chang Chien, Robert Schilling, Stephen Soviero, Patrick O'Donnell, Jane Ferguson, Lin Wu, Steven M. Anderson, Ha Bich Tran, H. Jeffrey Lawrence, Kenneth J. Bloom, Julie Tsai, Johnny Shyu, Felice Shieh, Wen Wei
Publikováno v:
BMC Cancer
Background Epidermal growth factor receptor (EGFR) gene mutations identify patients with non-small cell lung cancer (NSCLC) who have a high likelihood of benefiting from treatment with anti-EGFR tyrosine kinase inhibitors. Sanger sequencing is widely
Autor:
J. Li, A. Sims, K. Malhotra, Alan Blair, S. Gan, A. Tietz, Harkanwal Halait, Taraneh Rehage, Corey Hoeppner, Victoria H. Brophy, K. Min, M. Vinas
Publikováno v:
Annals of Oncology. 27:vi28
Autor:
Deborah Jensen, Robert Current, Jane Ferguson, Muskan Floren, Mandana Celeri, Patrick O'Donnell, Yiqiao Wu, Snehal Joshi, Taraneh Rehage, Theresa May, Stephen Soviero, Lilia Corona, Johnny Shyu, Kelli DeMartin
Publikováno v:
Journal of Clinical Oncology. 34:e23251-e23251
e23251Background: The cobas EGFR Mutation Test v2 (cobas EGFR test) is a real-time PCR test for the qualitative detection of 42 mutations in exons 18, 19, 20, and 21 of the epidermal growth factor ...
Autor:
Shih-Chang Chien, Julie Tsai, Robert Current, Johnny Shyu, Jane Ferguson, Taraneh Rehage, Mari Christensen, Ha Bich Tran, H. Jeffrey Lawrence, Patrick O'Donnell, Stephen Soviero, Wen Wei
Publikováno v:
Cancer Research. 72:1707-1707
EGFR mutations identify patients with NSCLC who have a high likelihood of benefiting from first-line treatment with anti-EGFR tyrosine kinase inhibitors. Sanger sequencing is widely used for mutation detection but can be time-consuming, and has limit